What one share of POMDOCTOR holds
We are a leading online medical services platform for chronic diseases in China, ranking sixth on China’s Internet hospital market measured by the number of contracted doctors in 2022, according to Frost & Sullivan.
POMDOCTOR’s numbers from its SEC filings, divided by its shares. Results cover the latest fiscal year to 2025-12-31; the balance sheet is as of 2025-12-31.
| Sales | $0.96 |
|---|---|
| Profit | −$0.51 |
| Capex (buildings and equipment) | $0.00 |
| Free cash flow | −$0.36 |
| Cash and investments | $0.02 |
| Debt | $0.33 |
| Book value | −$1.12 |
Per share by fiscal year
| Year | Sales | Profit | Capex | Free cash | Dividends | Book value |
|---|---|---|---|---|---|---|
| 2023 | $1.14 | −$0.54 | $0.00 | −$0.17 | — | −$7.89 |
| 2024 | $1.26 | −$0.53 | $0.00 | −$0.06 | — | −$8.19 |
| 2025 | $0.96 | −$0.51 | $0.00 | −$0.36 | — | −$1.12 |
Common questions about POMDOCTOR
How much does one share of POMDOCTOR earn?
Over its latest fiscal year, POMDOCTOR lost $0.51 for each share on $0.96 of sales.
Does POMDOCTOR pay a dividend?
POMDOCTOR didn’t pay a dividend over its latest fiscal year, according to its SEC filings.
What is POMDOCTOR’s book value per share?
POMDOCTOR’s book value is negative (−$1.12 per share): it owes more than everything it owns is recorded at, often after years of buying back its own shares, as of December 31, 2025.
How much cash and debt does each share of POMDOCTOR have?
Each share of POMDOCTOR has $0.02 of cash and investments and $0.33 of debt, as of December 31, 2025.
What is POMDOCTOR’s free cash flow per share?
−$0.36 per share over its latest fiscal year. Free cash flow is the cash left over after spending on buildings and equipment.
From its SEC filings. For education only, not investment advice. New to these words? See the StockSlicer glossary.